HUM, WLP And UNH, 3 Health Services Stocks Pushing The Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 59 points (-0.4%) at 16,657 as of Wednesday, May 14, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,380 issues advancing vs. 1,556 declining with 176 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.2%. On the negative front, top decliners within the industry include Align Technology ( ALGN), down 2.0%, PerkinElmer ( PKI), down 1.4%, Agilent Technologies ( A), down 1.5% and Stryker Corporation ( SYK), down 0.7%. A company within the industry that increased today was Grifols ( GRFS), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Humana ( HUM) is one of the companies pushing the Health Services industry lower today. As of noon trading, Humana is down $1.63 (-1.3%) to $120.29 on light volume. Thus far, 624,721 shares of Humana exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $119.88-$121.99 after having opened the day at $121.99 as compared to the previous trading day's close of $121.92.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in Retail, Employer Group, Healthcare Services, and Other Businesses segments. Humana has a market cap of $19.1 billion and is part of the health care sector. Shares are up 18.1% year-to-date as of the close of trading on Tuesday. Currently there are 10 analysts that rate Humana a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, WellPoint ( WLP) is down $0.63 (-0.6%) to $105.82 on light volume. Thus far, 875,494 shares of WellPoint exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $104.98-$106.40 after having opened the day at $106.15 as compared to the previous trading day's close of $106.45.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $29.9 billion and is part of the health care sector. Shares are up 15.2% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts that rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is down $0.74 (-0.9%) to $77.30 on light volume. Thus far, 1.1 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $77.11-$78.05 after having opened the day at $78.05 as compared to the previous trading day's close of $78.04.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $76.2 billion and is part of the health care sector. Shares are up 3.6% year-to-date as of the close of trading on Tuesday. Currently there are 15 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit